Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
2.100
+0.020 (0.96%)
At close: May 12, 2025, 4:00 PM
2.060
-0.040 (-1.90%)
After-hours: May 12, 2025, 6:04 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $51.16 million as of May 12, 2025.
Market Cap
51.16M
Enterprise Value
-100.80M
1-Year Change
n/a
Ranking
Category
Stock Price
2.10
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $51.16M, a decrease of -71.05%. That is a compound annual growth rate of -78.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 50.68M | -79.30% |
| Dec 31, 2024 | 244.84M | 38.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |